No Data
Market Flips and Falls as Meta and MSTR Fall After Earnings | Wall Street Today
Why Is Boston Scientific Stock Trading Lower On Wednesday?
Needham Maintains Boston Scientific(BSX.US) With Hold Rating
Market Climbs, SMCI Auditors Allege Mischief on Mischief Night | Live Stock
Boston Scientific's ACURATE Neo2 Aortic Valve System Fails To Meet Non-Inferiority In Key Trial, Showing 16.16% Composite Rate Of Mortality, Stroke, Or Rehospitalization At One Year Versus 9.53% For Control Valve; Data Presented At TCT 2024
Express News | Acurate Neo2™ Aortic Valve System Data Presented at Late-Breaking Clinical Trial Session at Tct 2024